U.S. flag

An official website of the United States government

NM_144997.7(FLCN):c.91C>T (p.Gln31Ter) AND Birt-Hogg-Dube syndrome

Germline classification:
Pathogenic (1 submission)
Last evaluated:
May 12, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003607382.2

Allele description [Variation Report for NM_144997.7(FLCN):c.91C>T (p.Gln31Ter)]

NM_144997.7(FLCN):c.91C>T (p.Gln31Ter)

Gene:
FLCN:folliculin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p11.2
Genomic location:
Preferred name:
NM_144997.7(FLCN):c.91C>T (p.Gln31Ter)
HGVS:
  • NC_000017.11:g.17228047G>A
  • NG_008001.2:g.14142C>T
  • NM_001353229.2:c.91C>T
  • NM_001353230.2:c.91C>T
  • NM_001353231.2:c.91C>T
  • NM_144606.7:c.91C>T
  • NM_144997.7:c.91C>TMANE SELECT
  • NP_001340158.1:p.Gln31Ter
  • NP_001340159.1:p.Gln31Ter
  • NP_001340160.1:p.Gln31Ter
  • NP_653207.1:p.Gln31Ter
  • NP_659434.2:p.Gln31Ter
  • LRG_325t1:c.91C>T
  • LRG_325:g.14142C>T
  • NC_000017.10:g.17131361G>A
  • NC_000017.10:g.17131361G>A
  • NM_144997.5:c.91C>T
Protein change:
Q31*
Links:
dbSNP: rs1597618162
NCBI 1000 Genomes Browser:
rs1597618162
Molecular consequence:
  • NM_001353229.2:c.91C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001353230.2:c.91C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001353231.2:c.91C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_144606.7:c.91C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_144997.7:c.91C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Birt-Hogg-Dube syndrome
Synonyms:
BHD syndrome; Birt Hogg Dubé syndrome
Identifiers:
MONDO: MONDO:0800444; MedGen: C0346010; Orphanet: 122; OMIM: PS135150

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004553466Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(May 12, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome.

Schmidt LS, Nickerson ML, Warren MB, Glenn GM, Toro JR, Merino MJ, Turner ML, Choyke PL, Sharma N, Peterson J, Morrison P, Maher ER, Walther MM, Zbar B, Linehan WM.

Am J Hum Genet. 2005 Jun;76(6):1023-33. Epub 2005 Apr 25.

PubMed [citation]
PMID:
15852235
PMCID:
PMC1196440

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004553466.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 823091). This variant has not been reported in the literature in individuals affected with FLCN-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln31*) in the FLCN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FLCN are known to be pathogenic (PMID: 15852235).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024